Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 957-965

  Kuball, Jürgen ^a   Wen, Shu Fen ^a   Leissner, Joachim ^a   Atkins, Derek ^a   Meinhardt, Patricia ^a   Quijano, Erlinda ^a   Engler, Heidrun ^a   Hutchins, Beth ^a   Maneval, Daniel C ^a   Grace, Michael J ^a   Fritz, Mary Ann ^a   Störkel, Stefan ^a   Thüroff, Joachim W ^a   Huber, Christoph ^a   Schuler, Martin ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIG CHAP; DRUG CARRIER; GENE PRODUCT; PROTEIN P53; SCH 58500; SIGNAL TRANSDUCTION ENHANCING AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADENOVIRUS; ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CYSTECTOMY; CYSTOSCOPY; DNA RECOMBINATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG INSTILLATION; DRUG PENETRATION; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSFER; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TRANSGENE; TREATMENT OUTCOME; VIRAL GENE THERAPY;

ADENOVIRIDAE; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 0037083558     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.957     Document Type: Article

References (43)

1. Global cancer statistics
2. The management of superficial bladder cancer
3. The biology and treatment of superficial bladder cancer
4. Prognostic markers in bladder cancer: A contemporary review of the literature
5. Carcinoma in situ of the bladder
6. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder
7. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and Bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer
8. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis)
9. Radical cystectomy for stages Ta, Tis and T 1 transitional cell carcinoma of the bladder
10. Radical cystprostatectomy combined with Mainz pouch bladder substitution to the urethra: Long-term results
11. Database of p53 gene somatic mutations in human tumors and cell lines
12. Surfing the p53 network
13. p53, the cellular gatekeeper for growth and division
14. Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after Bacillus Calmette-Guérin therapy: Correlation to clinical outcome
15. Accumulation of nuclear p53 and tumor progression in bladder cancer
16. Prognostic significance of histopathological grading and immunoreactivity for p53 and p21/WAF1 in grade 2 pTa transitional cell carcinoma of the urinary bladder
17. p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder: A helpful parameter in guiding the decision for or against cystectomy?
18. p53 tumor suppressor gene therapy for cancer
19. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
20. A phase I study of adenovirus mediated wild type p53 gene transfer in patients with advanced non-small cell lung cancer
21. Adenovirusmediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma
22. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
23. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours
24. Adenovirusmediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
25. Adenovirusmediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study
26. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma
27. Ethanol improves adenovirus-mediated gene transfer and expression to the bladder urothelium of rodents
28. Identification of polyamines that enhance adenoviral-mediated gene expression in the urothelium
29. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer
30. Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy
31. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
32. WAF1, a potential mediator of p53 tumor suppression
33. Detection of specific polymerase chain reaction product by utilizing 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase
34. A novel method for real time quantitative RT-PCR
35. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models
36. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
37. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
38. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
39. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies
40. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated p53 gene transfer in human bladder cancer model
41. Apoptotic pathways: Paper wraps stone blunts scissors
42. p21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients